| Descriptor English: | Matrix Metalloproteinase 16 | ||||||
| Descriptor Spanish: |
Metaloproteinasa 16 de la Matriz
| ||||||
| Descriptor Portuguese: | Metaloproteinase 16 da Matriz | ||||||
| Descriptor French: | Matrix metalloproteinase 16 | ||||||
| Entry term(s): |
MMP 16 Metalloproteinase MMP X2 Protein MMP-16 Metalloproteinase MMP-X2 Protein MMP16 Metalloproteinase MT3 Matrix Metalloproteinase MT3-MMP MT3-Matrix Metalloproteinase Matrix Metalloproteinase, Membrane-Type-3 Membrane Type 3 Matrix Metalloproteinase Membrane Type Matrix Metalloproteinase 3 Membrane-Type 3 Matrix Metalloproteinase Membrane-Type Matrix Metalloproteinase 3 Membrane-Type-3 Matrix Metalloproteinase Metalloproteinase, MMP-16 Metalloproteinase, MMP16 Metalloproteinase, Membrane-Type-3 Matrix |
||||||
| Tree number(s): |
D08.811.277.656.300.480.525.300.600 D08.811.277.656.675.374.525.300.750 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053513 | ||||||
| Scope note: | A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the proteolytic action of PROPROTEIN CONVERTASES. Matrix metalloproteinase 16 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of other MATRIX METALLOPROTEINASES such as the zymogen of MATRIX METALLOPROTEINASE 2. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Entry Combination: |
antagonists & inhibitors:Matrix Metalloproteinase Inhibitors
|
||||||
| Registry Number: | EC 3.4.24.- | ||||||
| Public MeSH Note: | 2007; MATRIX METALLOPROTEINASE 16 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 2005 |
||||||
| History Note: | 2007(2005) |
||||||
| DeCS ID: | 52235 | ||||||
| Unique ID: | D053513 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2007/01/01 | ||||||
| Date of Entry: | 2006/07/05 | ||||||
| Revision Date: | 2012/07/03 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
|
Matrix Metalloproteinase 16
- Preferred
| Concept UI |
M0284099 |
| Scope note | A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the proteolytic action of PROPROTEIN CONVERTASES. Matrix metalloproteinase 16 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of other MATRIX METALLOPROTEINASES such as the zymogen of MATRIX METALLOPROTEINASE 2. |
| Preferred term | Matrix Metalloproteinase 16 |
| Entry term(s) |
MMP 16 Metalloproteinase MMP X2 Protein MMP-16 Metalloproteinase MMP-X2 Protein MMP16 Metalloproteinase MT3 Matrix Metalloproteinase MT3-MMP MT3-Matrix Metalloproteinase Matrix Metalloproteinase, Membrane-Type-3 Membrane Type 3 Matrix Metalloproteinase Membrane Type Matrix Metalloproteinase 3 Membrane-Type 3 Matrix Metalloproteinase Membrane-Type Matrix Metalloproteinase 3 Membrane-Type-3 Matrix Metalloproteinase Metalloproteinase, MMP-16 Metalloproteinase, MMP16 Metalloproteinase, Membrane-Type-3 Matrix |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
